Medtronic plc (2M6.F)
| Previous close | 74.73 |
| Open | 73.89 |
| Bid | 74.35 x 100000 |
| Ask | 74.65 x 100000 |
| Day's range | 73.89 - 74.10 |
| 52-week range | 65.30 - 83.34 |
| Volume | |
| Avg. volume | 914 |
| Market cap | 98.699B |
| Beta (5Y monthly) | 0.78 |
| PE ratio (TTM) | 25.15 |
| EPS (TTM) | 2.94 |
| Earnings date | N/A |
| Forward dividend & yield | 2.57 (3.48%) |
| Ex-dividend date | 21 Mar 2024 |
| 1y target est | 145.56 |
PR NewswireMedtronic receives FDA approval for Inceptiv™ closed-loop spinal cord stimulator
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that the U.S. Food and Drug Administration (FDA) has approved the Inceptiv™ closed-loop rechargeable spinal cord stimulator (SCS) for the treatment of chronic pain. Inceptiv is the first Medtronic SCS device to offer a closed-loop feature that senses biological signals along the spinal cord and automatically adjusts stimulation in real time, keeping therapy in harmony with the motions of daily life.
Insider Monkey20 Fastest Growing Health Tech Companies in the World
In this article, we will be taking a look at the 20 fastest growing health tech companies in the world. If you do not want to learn about the trends in digital health market, head straight to the 5 Fastest Growing Health tech Companies in the World. Explosive Growth and Key Trends in the Digital […]
Simply Wall St.Calculating The Intrinsic Value Of Medtronic plc (NYSE:MDT)
Key Insights The projected fair value for Medtronic is US$100 based on 2 Stage Free Cash Flow to Equity With US$80.38...
